Announcements

Welcome to the MoFo Tech Blog

MoFo Tech brings together legal insights and in-depth analyses on trends and complex issues shaping the global technology industry, covering fields such as blockchain and distributed ledger, cloud and SaaS technologies, driverless cars, drones, FinTech, computer hardware and software, the IoT, semiconductors, and telecommunications.

June 18, 2025 - Tech Talks
Scaling Success, Powering Innovation – Exploring #NYTechWeek
By: Peter J. Fusco, Jesse Nevarez, Boris Segalis, William F. Wilson, Jae Zhou, Zainab Abdullah, Frank A. Paz and Jim Krenn
Morrison Foerster was proud to host a series of events during NY Tech Week that brought together tech enthusiasts and industry leaders. Our events offered unique experiences across Manhattan designed for founders and funders to network and level up on emerging technologies. Check out
... ›
June 04, 2025 - Artificial Intelligence
Subject Matter Eligibility of AI Medical Treatments
By: Jack Lane, Kenneth A. Kuwayti and Christopher Gloria
Artificial intelligence (AI) has quickly become a springboard for breakthroughs in personalized medicine, enhanced medical imaging, and predictive modeling for drug development.[1] And given the role it played in two recent Nobel Prizes—one in chemistry, and the other in physics—AI appears to have an
... ›
June 04, 2025 - Artificial Intelligence
Bipartisan Coalition Of State AGs Oppose Ten-Year AI Regulation Ban
By: Carrie H. Cohen, William F. Tarantino, Marian A. Waldmann Agarwal, Melissa M. Crespo, C.B. Rome and Katherine Wang
A coalition of 40 State AGs [1] sent a letter to Congressional leaders opposing a proposed 10-year ban on states enforcing any state law or regulation addressing artificial intelligence (“AI”). The ban was included by the House Energy and Commerce Committee as an amendment to
... ›
May 14, 2025 - Privacy + Data Security
Data Privacy at the Crossroads of AI and Life Sciences: U.S. and EU Perspectives
By: Melissa M. Crespo, Marijn Storm, Marian A. Waldmann Agarwal, Joshua R. Fattal and Katherine Wang
AI is transforming the life sciences industry by accelerating drug discovery and personalizing patient care. But as companies increasingly rely on AI to process genetic, biometric, and other types of health data, they must also comply with a constantly evolving data privacy, security, and
... ›
May 09, 2025 - Intellectual Property
Patent-Eligibility Considerations & Prosecution Strategies for AI-Based Life Sciences Patent Applications
By: Steve Sundberg Ph.D., Anna Yuan and Mehran Arjomand
Based on recent, dramatic advances in its predictive and generative capabilities, artificial intelligence (AI) is poised to revolutionize a variety of fields, including business, finance, manufacturing, information technology, and healthcare, with the potential to transform the global economy.1,2 AI is also increasingly being utilized
... ›
April 29, 2025 - Artificial Intelligence, Regulatory
AI Transparency in Healthcare: Navigating a Changing Regulatory Landscape
By: Marijn Storm, Brigid DeCoursey Bondoc and Elena Catherine Klonoski
Transparency of artificial intelligence ( AI ) systems in healthcare is quickly becoming a central concern for regulators due to potential impacts on patient safety, healthcare quality, bias mitigation, and public trust. To address these challenges, the Office of the National Coordinator for Health
... ›
April 22, 2025 - Artificial Intelligence
Recentive: Federal Circuit’s Patent-Eligibility Guideposts for Machine-Learning Inventions
By: Jonathan Bockman, Jeffrey Gerard Young, Anna Yuan, Joshua A. Crawford and Briana Erin Mittleman Ph.D.
In one of the first cases from the Federal Circuit addressing patent eligibility for machine-learning (ML) inventions, the court ruled that applying “generic” ML techniques to a new data environment to automate a task previously performed by humans—in this case, “event scheduling”—is an “abstract
... ›
April 14, 2025 - Artificial Intelligence
Japan’s Approach to AI Regulation in 2025
By: Seth M. Graham and Evan Y. Kim
Following Shigeru Ishiba’s appointment as Prime Minister on October 1, 2024, Japan has been charting a cautious but innovation-friendly AI regulation strategy, culminating in a public announcement by the Prime Minister himself on March 3, 2025, expressly favoring a regulatory framework that “promotes innovation”
... ›
April 09, 2025 - Artificial Intelligence, Intellectual Property
Federal Circuit Clarifies Requirements for Prior Art Under Pre-AIA 35 U.S.C. § 102(e)
By: Lisa N. Silverman Ph.D., Mehran Arjomand and Marisa B. Sanders Ph.D.
Knowing what qualifies as prior art is a core requirement of patent practitioners—whether in life sciences, in the technology sectors or in post-grant proceedings. It is important to keep abreast of changes to the rules, especially if the Federal Circuit weighs in. On March 24,
... ›
March 25, 2025 - Artificial Intelligence
AI Agent as a Service in Medtech - Key Considerations for Commercial Contracts
By: Matthew A. Ferry and Tricia Matibag
Artificial intelligence (AI) is transforming the medical technology (“medtech”) and healthcare industries through the integration of advanced AI agents. Unlike traditional AI systems that perform discrete, predefined tasks, AI agents are semi-autonomous software systems capable of independently making decisions traditionally reserved for humans, performing
... ›

Welcome to the MoFo Tech Blog

Scaling Success, Powering Innovation – Exploring #NYTechWeek

By: Peter J. Fusco, Jesse Nevarez, Boris Segalis, William F. Wilson, Jae Zhou, Zainab Abdullah, Frank A. Paz and Jim Krenn

Subject Matter Eligibility of AI Medical Treatments

By: Jack Lane, Kenneth A. Kuwayti and Christopher Gloria

Bipartisan Coalition Of State AGs Oppose Ten-Year AI Regulation Ban

By: Carrie H. Cohen, William F. Tarantino, Marian A. Waldmann Agarwal, Melissa M. Crespo, C.B. Rome and Katherine Wang

Data Privacy at the Crossroads of AI and Life Sciences: U.S. and EU Perspectives

By: Melissa M. Crespo, Marijn Storm, Marian A. Waldmann Agarwal, Joshua R. Fattal and Katherine Wang

Patent-Eligibility Considerations & Prosecution Strategies for AI-Based Life Sciences Patent Applications

By: Steve Sundberg Ph.D., Anna Yuan and Mehran Arjomand

AI Transparency in Healthcare: Navigating a Changing Regulatory Landscape

By: Marijn Storm, Brigid DeCoursey Bondoc and Elena Catherine Klonoski

Recentive: Federal Circuit’s Patent-Eligibility Guideposts for Machine-Learning Inventions

By: Jonathan Bockman, Jeffrey Gerard Young, Anna Yuan, Joshua A. Crawford and Briana Erin Mittleman Ph.D.

Japan’s Approach to AI Regulation in 2025

By: Seth M. Graham and Evan Y. Kim

Federal Circuit Clarifies Requirements for Prior Art Under Pre-AIA 35 U.S.C. § 102(e)

By: Lisa N. Silverman Ph.D., Mehran Arjomand and Marisa B. Sanders Ph.D.

AI Agent as a Service in Medtech - Key Considerations for Commercial Contracts

By: Matthew A. Ferry and Tricia Matibag